NCT06540703

Brief Summary

This is a longitudinal study with an open design in weight recovered anorexia nervosa (wrAN) individuals. Healthy controls (HC) will also be assessed. Study participants will be carefully assessed and will have 18F-fluorodeoxyglucose (\[18F\]FDG) positron emission tomography (PET) scans for assessment of regional brain glucose uptake. The wrAN group will be compared to healthy controls. Participants in the wrAN group will then complete 14 weeks of therapeutic ketogenic diet (TKD). At the end of the TKD study, participants will have assessments and a second \[18F\]FDG and TMS/EEG scan. Study participants will be followed over six months after the intervention. This follow-up procedure will help determine whether symptom improvement will be stable or worsen in individuals who choose to continue or discontinue the TKD intervention. This will be a naturalistic follow-up.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
44mo left

Started Oct 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Oct 2024Jan 2030

First Submitted

Initial submission to the registry

August 2, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

October 2, 2024

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

4.6 years

First QC Date

August 2, 2024

Last Update Submit

April 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • [18F]fluorodeoxyglucose (FDG) uptake

    To test whether TKD will be associated with reduced brain \[18F\]fluorodeoxyglucose (FDG) uptake

    Difference in pre/post Therapeutic Ketogenic Diet PET/CT scans

Study Arms (1)

Therapeutic Ketogenic Diet

EXPERIMENTAL

Subjects will be placed on a therapeutic ketogenic diet (TKD) for a duration of 14 weeks.

Dietary Supplement: Therapeutic Ketogenic Diet (TKD)

Interventions

2 week induction to establish ketosis followed by 12 weeks therapeutic ketogenic diet

Therapeutic Ketogenic Diet

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Weight Recovered Anorexia Nervosa (wrAN)
  • Age 18-45 years old
  • Male and Female sexes
  • All ethnic backgrounds
  • History of restricting-type anorexia nervosa (AN) according to DSM-5 criteria
  • Weight recovered with a body mass index \> 17.5 for at least one month at the time of study
  • Elevated eating disorder-relevant behaviors on the Eating Disorders Inventory-3 and the Eating Disorder Examination Questionnaire
  • Healthy Control Group
  • Age 18-45 years old
  • Male and Female sexes
  • All ethnic backgrounds
  • Normal lifetime BMI according to CDC

You may not qualify if:

  • Weight Recovered Anorexia Nervosa (AN)
  • Current pregnancy or nursing (will have to agree to contraceptive measures if sexually active)
  • Lifetime history of bipolar I disorder or psychosis
  • Current substance abuse or dependence in the past 3 months
  • Psychotic illness/other organic brain syndromes, dementia, somatization disorders or conversion disorders
  • History of significant head trauma
  • Indication of intellectual disability or autism spectrum disorder
  • Healthy Control Group
  • No lifetime psychiatric illness and in particular no eating disorder history
  • Not be taking medication, and will not have a first degree relative with an eating disorder.
  • No subject in either group will have or be
  • mental retardation or pervasive developmental disorder
  • organic brain syndrome
  • dementia
  • psychotic disorder
  • +10 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Diego

San Diego, California, 92121, United States

RECRUITING

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: therapeutic ketogenic diet for 14 weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 2, 2024

First Posted

August 6, 2024

Study Start

October 2, 2024

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

January 1, 2030

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations